TrialHealth technology assessment (Winchester, England)2019

Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.

Clara Carreras-Abad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.